Troy Edward Wilson Insider Trades
President and CEOPresident and CEO at Kura Oncology, Inc.. 2 significant open-market trades reported on SEC Form 4 in the last 180 days.
On EDGAR, this filer has 71 Form 4 filings on record since 2013, the latest on Sep 16, 2026. Full history on sec.gov
$2.4M
Bought
$0
Sold
2 / 0
Buys / Sells
1
Companies
Companies
- KURAPresident and CEO
Kura Oncology, Inc.
2 buys, $2.4M · 1 alert in our log
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.
- Mollie LeoniChief Medical Officer at KURA1 sell, $440K
- Brian T. PowlChief Commercial Officer at KURA1 sell, $345K
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.